PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
encephalitis10.47936/encephalitis.2022.0012920233271-77Myelin oligodendrocyte glycoprotein antibody-associated encephalitis after severe acute respiratory syndrome coronavirus 2 infection: a case report and retrospective case reviewsYoonkyung Lee, Seon-Jae Ahn, Han-Sang Lee, Yongmoo Kim, Seolah Lee, Hyeyoung Park, Jangsup Moon, Sang Kun Lee, Kon Chuhttp://encephalitisjournal.org/upload/pdf/encephalitis-2022-00129.pdf, http://encephalitisjournal.org/journal/view.php?doi=10.47936/encephalitis.2022.00129, http://encephalitisjournal.org/upload/pdf/encephalitis-2022-00129.pdf
Reactions Weekly10.1007/s40278-023-46700-3202319751345-345Severe-acute-respiratory-syndrome-coronavirus-2-mRNA-vaccinehttps://link.springer.com/content/pdf/10.1007/s40278-023-46700-3.pdf, https://link.springer.com/article/10.1007/s40278-023-46700-3/fulltext.html, https://link.springer.com/content/pdf/10.1007/s40278-023-46700-3.pdf
Clinical and Experimental Pediatrics10.3345/cep.2020.019632021646310-312Myelin oligodendrocyte glycoprotein antibody encephalitis following severe acute respiratory syndrome coronavirus 2 in a pediatric patientNusrat Ahsan, Saba Jafarpour, Jonathan D. Santorohttp://e-cep.org/upload/pdf/cep-2020-01963.pdf, http://e-cep.org/journal/view.php?doi=10.3345/cep.2020.01963, http://e-cep.org/upload/pdf/cep-2020-01963.pdf
Multiple Sclerosis and Related Disorders10.1016/j.msard.2020.102033202041102033Self-remitting cerebral cortical encephalitis associated with myelin oligodendrocyte glycoprotein antibody mimicking acute viral encephalitis: A case reportTai Otani, Takashi Irioka, Susumu Igarashi, Kimihiko Kaneko, Toshiyuki Takahashi, Takanori Yokotahttps://api.elsevier.com/content/article/PII:S2211034820301097?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S2211034820301097?httpAccept=text/plain
Autoimmune Encephalitis and Related Disorders of the Nervous System10.1017/9781108696722.0112022290-314Acute Disseminated Encephalomyelitis and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Diseasehttps://www.cambridge.org/core/services/aop-cambridge-core/content/view/29FE10420E420632C022DE2DEE61064E
Reactions Weekly10.1007/s40278-023-45995-6202319731267-267Tozinameranhttps://link.springer.com/content/pdf/10.1007/s40278-023-45995-6.pdf, https://link.springer.com/article/10.1007/s40278-023-45995-6/fulltext.html, https://link.springer.com/content/pdf/10.1007/s40278-023-45995-6.pdf
Reactions Weekly10.1007/s40278-022-20667-4202219181210-210Elasomeranhttps://link.springer.com/content/pdf/10.1007/s40278-022-20667-4.pdf, https://link.springer.com/article/10.1007/s40278-022-20667-4/fulltext.html, https://link.springer.com/content/pdf/10.1007/s40278-022-20667-4.pdf
Reactions Weekly10.1007/s40278-022-21930-y202219201393-393Pembrolizumabhttps://link.springer.com/content/pdf/10.1007/s40278-022-21930-y.pdf, https://link.springer.com/article/10.1007/s40278-022-21930-y/fulltext.html, https://link.springer.com/content/pdf/10.1007/s40278-022-21930-y.pdf
Reactions Weekly10.1007/s40278-022-13731-0202219031169-169Elasomeranhttps://link.springer.com/content/pdf/10.1007/s40278-022-13731-0.pdf, https://link.springer.com/article/10.1007/s40278-022-13731-0/fulltext.html, https://link.springer.com/content/pdf/10.1007/s40278-022-13731-0.pdf
Reactions Weekly10.1007/s40278-022-18126-y202219121423-423Tozinameranhttps://link.springer.com/content/pdf/10.1007/s40278-022-18126-y.pdf, https://link.springer.com/article/10.1007/s40278-022-18126-y/fulltext.html, https://link.springer.com/content/pdf/10.1007/s40278-022-18126-y.pdf